Scientists track rare brain diseases to pave way for future cures

NCT ID NCT00668187

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study follows children and adults with Tay-Sachs, Sandhoff, and GM1 gangliosidosis to understand how these diseases progress. Researchers will measure changes in motor skills, communication, and behavior each year. The goal is to create a clear picture of the diseases so future treatments, like gene therapy, can be tested effectively.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this study will provide crucial data to design future therapies and clinical trials for these rare diseases.

What could go wrong

This is an observational study, not a treatment trial. It does not test any intervention, so there is no direct benefit to participants.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GM1 GANGLIOSIDOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Gangliosidoses GM1 gangliosidosis GM2 gangliosidosis Sandhoff disease Tay-Sachs disease Tay-Sachs disease, B variant, adult form Tay-Sachs Disease, Juvenile

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Minnesota - Pediatric Genetics and Metabolism

    RECRUITING

    Minneapolis, Minnesota, 55455, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact